RT Answers News Archive
— Navy.mil -- November 5, 2009
A Naval Reserve Officers Training Corps (NROTC) instructor was awarded the American Society for Radiation Oncology (ASTRO) 2009 Survivor Circle Award during an awards ceremony at McCormick Place West in Chicago Nov. 3.
— Chicago Tribune -- November 4, 2009
Edward Schrank sees the bald heads and bodies emaciated from cancer at Northwestern University's oncology center on Chicago's Gold Coast, and it is as if he is surveying his domain.
— Reuters -- November 4, 2009
According to a study presented November 4, 2009, at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), a shortened, more intensive course of radiation given to the whole breast, along with an extra dose of radiation given to the surgical bed of the tumor (concomitant boost), has been shown to result in excellent local control at a median follow up of two years after treatment with no significant side effects.
— WebMD -- November 4, 2009
A boost of a highly targeted form of radiation therapy may prevent prostate cancer from coming back, a study of nearly 400 men suggests.
— Web MD -- November 4, 2009
If you had cancer, would you want to be told your odds of dying? Absolutely, suggests a survey of more than 500 people with breast, lung and prostate cancer.
— U.S. News and World Report -- November 2, 2009
A brief course of hormone-blocking therapy can provide small benefits to a specific group of men who get radiation therapy for prostate cancer, a long-running study shows.
— Atlanta Journal-Constitution -- November 2, 2009
Patients whose melanoma has spread to one or more lymph nodes face a decreased risk of the deadly skin cancer returning if they have radiation treatment following the removal of the nodes, a new Australian study shows.
— www.dotmed.com
Red wine may prevent radiation-induced skin toxicity in breast cancer patients, according to a study by Dr. Gabriella Macchia, of Catholic University, Campobasso, Italy.
— www.sciencedaily.com
Moderately to severely obese prostate cancer patients may have improved treatment outcomes when treated with image-guided radiation therapy (IGRT) over traditional external beam radiation therapy (EBRT) because IGRT corrects for prostate shifts, which, if not planned for, can lead to incorrect doses of radiation to the disease site, according to a study in the September 1 issue of the International Journal of Radiation Oncology *Biology* Physics, the official journal of the American Society for Radiation Oncology (ASTRO).
